Impact of NS5A sequences of hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon-α2a plus ribavirin

15Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Background. Hepatitis C virus (HCV) genotype 1 is the most prevalent genotype in Western countries, and treatment with pegylated interferon (pegIFN) plus ribavirin fails in 50%-60% of patients. Genetic variability within the NS5A dsRNA-dependent protein kinase binding domain (PKRbd) of HCV-1b has been associated with responsiveness to IFN-α. Little is known about NS5A sequences of HCV-1a. We investigated whether genetic variability of HCV-1a NS5A correlates with the early HCV kinetics during treatment. Methods. Twenty-four treatment-naive, HCV-1a-infected patients were treated with standard doses of pegIFN-α2a plus ribavirin. HCV viremia was quantitated at days 0, 1, 2, and 3 and weeks 1, 2, 4, 8, and 12 of treatment. According to HCV kinetics, patients were classified as early rapid responders, early moderate responders, or early slow responders. The full-length HCV NS5A was sequenced at baseline and at week 1. Results. At baseline, variability of the NS5A C terminus (concentrated in the PKRbd) is associated with interferon efficacy but not with the second phase of the early viral decline that has been associated with a sustained virologic response. Comparisons between baseline and week-1 full-length sequences did not show significant increases in mutations. Conclusions. Genetic variability of HCV-1a NS5A does not predict responsiveness to IFN-α. Differences in early kinetics during combination therapy are not due to selection of IFN-resistant HCV strains. © 2007 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Dal Pero, F., Tang, K. H., Gerotto, M., Bortoletto, G., Paulon, E., Herrmann, E., … Naoumov, N. V. (2007). Impact of NS5A sequences of hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon-α2a plus ribavirin. Journal of Infectious Diseases, 196(7), 998–1005. https://doi.org/10.1086/521306

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free